Cargando…
Broad Reactivity Single Domain Antibodies against Influenza Virus and Their Applications to Vaccine Potency Testing and Immunotherapy
The antigenic variability of influenza presents many challenges to the development of vaccines and immunotherapeutics. However, it is apparent that there are epitopes on the virus that have evolved to remain largely constant due to their functional importance. These more conserved regions are often...
Autores principales: | Tung Yep, Andrew, Takeuchi, Yasu, Engelhardt, Othmar G., Hufton, Simon E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8001348/ https://www.ncbi.nlm.nih.gov/pubmed/33802072 http://dx.doi.org/10.3390/biom11030407 |
Ejemplares similares
-
Cross-Reactive and Lineage-Specific Single Domain Antibodies against Influenza B Hemagglutinin
por: Ramage, Walter, et al.
Publicado: (2019) -
Development of an ELISA-Based Potency Assay for Inactivated Influenza Vaccines Using Cross-Reactive Nanobodies
por: Cheung, Chung Y., et al.
Publicado: (2022) -
The Breadth of Cross Sub-Type Neutralisation Activity of a Single Domain Antibody to Influenza Hemagglutinin Can Be Increased by Antibody Valency
por: Hufton, Simon E., et al.
Publicado: (2014) -
Protection From Influenza by Intramuscular Gene Vector Delivery of a Broadly Neutralizing Nanobody Does Not Depend on Antibody Dependent Cellular Cytotoxicity
por: Del Rosario, Joanne Marie M., et al.
Publicado: (2020) -
Nanobodies mapped to cross-reactive and divergent epitopes on A(H7N9) influenza hemagglutinin using yeast display
por: Gaiotto, Tiziano, et al.
Publicado: (2021)